title: Assessing subject privacy and data confidentiality in an emerging region for clinical trials: United Arab Emirates.
abstract: Pharmaceutical sponsored clinical trials, formerly conducted predominantly in the United States and Europe, have expanded to emerging regions, including the Middle East. Our study explores factors influencing clinical trial privacy and confidentiality in the United Arab Emirates. Factors including concept familiarity, informed consent compliance, data access, and preservation, were analyzed to assess current practices in the Arab world. As the UAE is an emerging region for clinical trials, there is a growing need for regulations related to data confidentiality and subject privacy. Informational and decisional privacy should be viewed within the realms of Arab culture and religious background.
authors.affiliation: a Department of Academic Affairs , Tawam Hospital , Al Ain , United Arab Emirates.
authors.forename: Satish Chandrasekhar
authors.initials: SC
authors.lastname: Nair
authors.forename: Halah
authors.initials: H
authors.lastname: Ibrahim
mesh_terms: D002986:Clinical Trials as Topic / Q000941:ethics*; D003219:Confidentiality / Q000941:ethics* / Q000331:legislation & jurisprudence; D003466:Cultural Characteristics; D003906:Developing Countries; D006801:Humans; D020380:Needs Assessment; D018907:Privacy / Q000331:legislation & jurisprudence*; D012307:Risk Factors; D014479:United Arab Emirates
keywords: culture; privacy and confidentiality; regulatory